MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine
Open Access
- 24 January 2011
- Vol. 66 (5), 596-604
- https://doi.org/10.1111/j.1398-9995.2010.02534.x
Abstract
To cite this article: Bousquet J, Anto J, Auffray C, Akdis M, Cambon‐Thomsen A, Keil T, Haahtela T, Lambrecht BN, Postma DS, Sunyer J, Valenta R, Akdis CA, Annesi‐Maesano I, Arno A, Bachert C, Ballester F, Basagana X, Baumgartner U, Bindslev‐Jensen C, Brunekreef B, Carlsen KH, Chatzi L, Crameri R, Eveno E, Forastiere F, Garcia‐Aymerich J, Guerra S, Hammad H, Heinrich J, Hirsch D, Jacquemin B, Kauffmann F, Kerkhof M, Kogevinas M, Koppelman GH, Kowalski ML, Lau S, Lodrup‐Carlsen KC, Lopez‐Botet M, Lotvall J, Lupinek C, Maier D, Makela MJ, Martinez FD, Mestres J, Momas I, Nawijn MC, Neubauer A, Oddie S, Palkonen S, Pin I, Pison C, Rancé F, Reitamo S, Rial‐Sebbag E, Salapatas M, Siroux V, Smagghe D, Torrent M, Toskala E, van Cauwenberge P, van Oosterhout AJM, Varraso R, von Hertzen L, Wickman M, Wijmenga C, Worm M, Wright J, Zuberbier T. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596–604. Abstract The origin of the epidemic of IgE‐associated (allergic) diseases is unclear. MeDALL (Mechanisms of the Development of ALLergy), an FP7 European Union project (No. 264357), aims to generate novel knowledge on the mechanisms of initiation of allergy and to propose early diagnosis, prevention, and targets for therapy. A novel phenotype definition and an integrative translational approach are needed to understand how a network of molecular and environmental factors can lead to complex allergic diseases. A novel, stepwise, large‐scale, and integrative approach will be led by a network of complementary experts in allergy, epidemiology, allergen biochemistry, immunology, molecular biology, epigenetics, functional genomics, bioinformatics, computational and systems biology. The following steps are proposed: (i) Identification of ‘classical’ and ‘novel’ phenotypes in existing birth cohorts; (ii) Building discovery of the relevant mechanisms in IgE‐associated allergic diseases in existing longitudinal birth cohorts and Karelian children; (iii) Validation and redefinition of classical and novel phenotypes of IgE‐associated allergic diseases; and (iv) Translational integration of systems biology outcomes into health care, including societal aspects. MeDALL will lead to: (i) A better understanding of allergic phenotypes, thus expanding current knowledge of the genomic and environmental determinants of allergic diseases in an integrative way; (ii) Novel diagnostic tools for the early diagnosis of allergy, targets for the development of novel treatment modalities, and prevention of allergic diseases; (iii) Improving the health of European citizens as well as increasing the competitiveness and boosting the innovative capacity of Europe, while addressing global health issues and ethical issues.Keywords
This publication has 29 references indexed in Scilit:
- Refining the definition of hypereosinophilic syndromeJournal of Allergy and Clinical Immunology, 2010
- Gene-environment interactions in asthmaJournal of Allergy and Clinical Immunology, 2009
- Asthma in Latin America: a public heath challenge and research opportunityAllergy, 2008
- Effect of 17q21 Variants and Smoking Exposure in Early-Onset AsthmaThe New England Journal of Medicine, 2008
- Gene–Environment Interaction in Complex Diseases: Asthma as an Illustrative CasePublished by Wiley ,2008
- Variants in common diseasesNature, 2007
- Genes, environments, development and asthma: a reappraisalEuropean Respiratory Journal, 2006
- Heterogeneity of the Association between Lower Respiratory Illness in Infancy and Subsequent AsthmaProceedings of the American Thoracic Society, 2005
- Epigenetic inheritance of fetal genes in allergic asthmaAllergy, 2004
- Atopic dermatitis and the atopic marchJournal of Allergy and Clinical Immunology, 2003